References
- Caumes E, Datry A, Paris L, et al. Efficacy of ivermectin in the therapy of cutaneous larva migrans. Arch Dermatol. 1992;128:994–5.
- Louis FJ, De Quincenet G, Louis JP. Intérêt de l’ivermectine en prise unique dans le traitement du syndrome de larva migrans cutanée. Presse Med. 1992;2:1483.
- Caumes E, Carriere J, Datry A, et al. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg. 1993;49:641–4.
- Bouchaud O, Houzé S, Schiemann R, et al. Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin. Clin Infect Dis. 2000;3:493–8.
- Caumes E. Treatment of cutaneous larva migrans. Clin Infect Dis. 2000;3:811–14.
- Caumes E, Ly F Bricaire F. Cutaneous larva migrans with folliculitis: report of seven cases and review of the literature. Br J Dermatol. 2002;1:314–16.
- Cayce KA, Scott CM, Phillips CM, et al. What is your diagnosis? The diagnosis: cutaneous larva migrans. Cutis. 2007;7:435–6.
- Herrmann A, Christoph T, Sebastian G. Larva migrans “saxoniae”: Auftreten einer Infektion mit larva migrans in Sachsen. J Dtsch Dermatol. 2004;2:46–8.
- Del Mar Sáez-de-Ocariz M, Durán McKinster C, Orozco-Covarrubias L, et al. Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin. Clin Exp Dermatol. 2002;27:264–7.